Evaluation of Potential Predictors of Disease Progression in Participants With Atypical Hemolytic Uremic Syndrome (aHUS) Including Genetics, Biomarkers, and Treatment

NCT02614898 · clinicaltrials.gov ↗
TERMINATED
Status
67
Enrollment
INDUSTRY
Sponsor class

Stopped Terminated for administrative reasons before enrollment was complete.

Conditions

Interventions

Sponsor

Alexion Pharmaceuticals, Inc.